Literature DB >> 28495674

Noncentral Nervous System Systemic Embolism in Patients With Atrial Fibrillation: Results From ROCKET AF (Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation).

Ryan Orgel1, Daniel Wojdyla1, David Huberman1, Jonathan L Halperin1, Günter Breithardt1, Daniel E Singer1, Keith A A Fox1, Graeme J Hankey1, Kenneth W Mahaffey1, W Schuyler Jones2, Manesh R Patel1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28495674      PMCID： PMC5485838          DOI： 10.1161/CIRCOUTCOMES.116.003520

Source DB:  PubMed          Journal:  Circ Cardiovasc Qual Outcomes        ISSN： 1941-7713


× No keyword cloud information.
  10 in total

1.  Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.

Authors:  Manesh R Patel; Kenneth W Mahaffey; Jyotsna Garg; Guohua Pan; Daniel E Singer; Werner Hacke; Günter Breithardt; Jonathan L Halperin; Graeme J Hankey; Jonathan P Piccini; Richard C Becker; Christopher C Nessel; John F Paolini; Scott D Berkowitz; Keith A A Fox; Robert M Califf
Journal:  N Engl J Med       Date:  2011-08-10       Impact factor: 91.245

2.  Trends in the incidence, treatment, and outcomes of acute lower extremity ischemia in the United States Medicare population.

Authors:  Donald T Baril; Kaushik Ghosh; Allison B Rosen
Journal:  J Vasc Surg       Date:  2014-04-24       Impact factor: 4.268

Review 3.  Thromboembolic complications in atrial fibrillation.

Authors:  P Petersen
Journal:  Stroke       Date:  1990-01       Impact factor: 7.914

4.  Rivaroxaban-once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: rationale and design of the ROCKET AF study.

Authors: 
Journal:  Am Heart J       Date:  2010-03       Impact factor: 4.749

5.  Twenty-year analysis of trends in the incidence and in-hospital mortality for lower-extremity arterial thromboembolism.

Authors:  Ravikiran Korabathina; Andrew R Weintraub; Lori Lyn Price; Navin K Kapur; Carey D Kimmelstiel; Mark D Iafrati; Syed M Ali Tahir
Journal:  Circulation       Date:  2013-06-05       Impact factor: 29.690

6.  Incident thromboembolism in the aorta and the renal, mesenteric, pelvic, and extremity arteries after discharge from the hospital with a diagnosis of atrial fibrillation.

Authors:  L Frost; G Engholm; S Johnsen; H Møller; E W Henneberg; S Husted
Journal:  Arch Intern Med       Date:  2001-01-22

7.  Systemic, noncerebral, arterial embolism in 21,105 patients with atrial fibrillation randomized to edoxaban or warfarin: results from the Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction Study 48 trial.

Authors:  Bram J Geller; Robert P Giugliano; Eugene Braunwald; Sabina A Murphy; James J Hanyok; Jianqing Jin; Michele Mercuri; Elliott M Antman; Christian T Ruff
Journal:  Am Heart J       Date:  2015-07-02       Impact factor: 4.749

Review 8.  Thromboembolism associated with atrial fibrillation as a cause of limb and organ ischemia.

Authors:  Marta Wasilewska; Izabela Gosk-Bierska
Journal:  Adv Clin Exp Med       Date:  2013 Nov-Dec       Impact factor: 1.727

9.  Extracranial Systemic Embolic Events in Patients With Nonvalvular Atrial Fibrillation: Incidence, Risk Factors, and Outcomes.

Authors:  Wobo Bekwelem; Stuart J Connolly; Jonathan L Halperin; Selcuk Adabag; Sue Duval; Susan Chrolavicius; Janice Pogue; Michael D Ezekowitz; John W Eikelboom; Lars G Wallentin; Salim Yusuf; Alan T Hirsch
Journal:  Circulation       Date:  2015-07-29       Impact factor: 29.690

10.  Systemic Embolic Events (SEE) in Atrial Fibrillation: SEEing Embolic Risk More Clearly.

Authors:  Neal A Chatterjee; Steven A Lubitz
Journal:  Circulation       Date:  2015-07-29       Impact factor: 29.690
  10 in total
  2 in total

1.  Relationship Between Visceral Infarction and Ischemic Stroke Subtype.

Authors:  Caitlin Finn; Peter Hung; Praneil Patel; Ajay Gupta; Hooman Kamel
Journal:  Stroke       Date:  2018-01-25       Impact factor: 7.914

2.  Clinical characteristics and thrombotic risk of atrial fibrillation with obstructive sleep apnea: results from a multi-center atrial fibrillation registry study.

Authors:  Wei Xu; Yan-Min Yang; Jun Zhu; Shuang Wu; Juan Wang; Han Zhang; Xing-Hui Shao; Ran Mo; Jiang-Shan Tan; Jing-Yang Wang
Journal:  BMC Cardiovasc Disord       Date:  2022-07-25       Impact factor: 2.174
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.